Artra Group Corporation
Notice of Nagoya Stock Exchange First Section Listing Approval
Upon approval for listing on the Nagoya Exchange's Main Market, we will apply for simultaneous listing on the Tokyo Stock Exchange's Standard Market. The listing date is September 17, 2026, with the aim of improving liquidity and expanding the investor base.
Key Figures
- Listing date: 2026-09-17
- Dual listing: Nagoya Stock Exchange Main Market and Tokyo Stock Exchange Standard Market
- Target business: Acupuncture and manual therapy clinic management support platform 'A-COMS'
AI要約
Summary of the News
This is a notice regarding listing approval on the Nagoya Stock Exchange’s Main Market. The company, whose core business is the acupuncture and manual therapy clinic management support platform 'A-COMS,' will commence dual listing on the Tokyo Stock Exchange's Standard Market and the Nagoya Exchange. The goals are to expand the investor base and recognition, improve stock liquidity, and enhance dialogue with shareholders.
Upcoming Schedule and Impact
The listing is scheduled for September 17, 2026. Thereafter, the company's shares will be tradable on both markets. The details of the Nagoya market will be referenced by the company, and through IR activities the company will continue to disclose information and engage in dialogue to enhance corporate value.
Atra Group Co., Ltd.
Company overview · Stock price · Financial data · All IR
